Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC
Sponsor: Eikon Therapeutics
Summary
This study is for patients with advanced/metastatic non-small cells lung cancer (NSCLC) who have not received any treatment through the vein for the advanced disease.
Official title: A Phase 2 Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Patients With Stage 4 Non-Small Cell Lung Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2024-02-06
Completion Date
2027-12
Last Updated
2025-11-12
Healthy Volunteers
No
Conditions
Interventions
EIK1001
EIK1001 is a Toll like receptor 7/8 (TLR 7/8) agonist
Pembrolizumab
PD-1 inhibitor
Paclitaxel
Chemotherapy
Pemetrexed
Chemotherapy
Carboplatin
Chemotherapy
Locations (39)
Southern Cancer Care
Daphne, Alabama, United States
Ironwood Cancer and Research Center
Chandler, Arizona, United States
California Cancer Care Associates for Research & Excellence
Fresno, California, United States
California Research Institute
Los Angeles, California, United States
University of Southern California, Norris Comprehensive Cancer Center
Los Angeles, California, United States
Providence St Joseph Hospital, Center for Cancer Prevention and Treatment
Orange, California, United States
Sutter Health Institute for Medical Research
Sacramento, California, United States
Rocky Mountain Cancer
Lone Tree, Colorado, United States
Bioresearch Partner
Hialeah, Florida, United States
Memorial Cancer Institute
Hollywood, Florida, United States
Mid-Florida Hematology and Oncology Center
Orange, Florida, United States
Orlando Health Cancer Institute
Orlando, Florida, United States
Moffitt Cancer Center
Tampa, Florida, United States
Atlanta Piedmont Hospital
Atlanta, Georgia, United States
Kaiser Permanente Hawaii
Honolulu, Hawaii, United States
Illinois Cancer Specialists
Niles, Illinois, United States
Accelacare of Duly
Tinley Park, Illinois, United States
Indiana University Cancer Center
Indianapolis, Indiana, United States
Health Midwest Oncology Associates of Kansas
Overland Park, Kansas, United States
Cancer Center of Kansas
Wichita, Kansas, United States
Medstar Franklin Square Cancer Center at Loch Raven Campus
Baltimore, Maryland, United States
Maryland Oncology
Columbia, Maryland, United States
Jersey Shore University Medical Center/Meridian Hematology & Oncology
Neptune City, New Jersey, United States
New York Cancer and Blood Specialists
Babylon, New York, United States
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
New York, New York, United States
Weil Cornell Medical Center
New York, New York, United States
Albert Einstein College of Medicine, Jacobi Medical Center
The Bronx, New York, United States
Cancer and Blood Specialists of New York, White Plains Hospital
White Plains, New York, United States
Messino Cancer Centers
Asheville, North Carolina, United States
Gabrail Cancer Center
Canton, Ohio, United States
Willamette Valley
Eugene, Oregon, United States
Tennessee Cancer Specialists
Knoxville, Tennessee, United States
Baptist Cancer Center
Memphis, Tennessee, United States
Texas Oncology, Austin
Austin, Texas, United States
Texas Oncology, Bedford
Bedford, Texas, United States
The Center for Cancer and Blood Disorders
Fort Worth, Texas, United States
Blue Ridge Cancer Care Oncology Associates SW VA
Blacksburg, Virginia, United States
Virginia Cancer Specialists
Fairfax, Virginia, United States
Shenandoah Oncology
Winchester, Virginia, United States